Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria

Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-Lactamase

(2012) Peter S. Levitt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding

(2012) Sugunadevi Sakkiah et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Structure-Based Design of Potent and Ligand-Efficient Inhibitors of CTX-M Class A β-Lactamase

(2012) Derek A. Nichols et al.   JOURNAL OF MEDICINAL CHEMISTRY

Virtual Screening, Identification and In Vitro Testing of Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of Entamoeba histolytica

(2012) Isha Nagpal et al.   PLoS One

Efficacy of E. officinalis on the Cariogenic Properties of Streptococcus mutans: A Novel and Alternative Approach to Suppress Quorum-Sensing Mechanism

(2012) Sadaf Hasan et al.   PLoS One

Prevalence of plasmid mediated blaTEM-1 and blaCTX-M-15 type extended spectrum beta–lactamases in patients with sepsis

(2012) Shahzad F Haque et al.   Asian Pacific Journal of Tropical Medicine

Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes

(2011) Matthew E Falagas et al.   Future Microbiology

Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008

(2010) M. G. Goren et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2  -Lactamase

(2010) K. M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: First boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity

(2010) Qiang Tan et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Elucidating the role of Trp105 in the KPC-2 β-lactamase

(2010) Krisztina M. Papp-Wallace et al.   PROTEIN SCIENCE

Inhibitor Resistance in the KPC-2  -Lactamase, a Preeminent Property of This Class A  -Lactamase

(2009) K. M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

(2009) A. Endimiani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES

Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom

(2008) N. Woodford et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY